Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 18/20 | 0.46 |
| ▸ | PPARA | Q07869 | 11/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.41 |
| ▸ | PTGES | O14684 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | PPARD | Q03181 | 2/20 | 0.39 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6939444 | 1.00 | PPARG (0.46) | PPARGPPARAALOX5PTGESCYP1A2 | |
| SCHEMBL6937238 | 0.93 | PPARG (0.44) | PPARGPPARAALOX5PTGESCYP1A2 | |
| SCHEMBL6937241 | 0.93 | PPARG (0.44) | PPARGPPARAALOX5PTGESCYP1A2 | |
| SCHEMBL6936009 | 0.91 | PPARG (0.47) | PPARGPPARACYP1A2CYP2D6CYP19A1 | |
| SCHEMBL6936011 | 0.91 | PPARG (0.47) | PPARGPPARACYP1A2CYP2D6CYP19A1 | |
| SCHEMBL6939474 | 0.90 | PPARG (0.46) | PPARGPPARACYP1A2CYP2D6CYP19A1 | |
| SCHEMBL6939476 | 0.90 | PPARG (0.46) | PPARGPPARACYP1A2CYP2D6CYP19A1 | |
| SCHEMBL6933275 | 0.88 | PPARG (0.44) | PPARGPPARAALOX5PTGESCYP1A2 | |
| SCHEMBL6933273 | 0.88 | PPARG (0.44) | PPARGPPARAALOX5PTGESCYP1A2 | |
| SCHEMBL6933885 | 0.85 | PPARG (0.57) | PPARGPPARACYP1A2CYP2D6CYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0916651-B1 | PHENYLALKYLCARBOXYLIC ACID DERIVATIVES | SANKYO CO (JP) | 2003-10-15 | — | — | EP | claimed |
| US-6103907-A | ALDOSE REDUCTASE INHIBITING ANTIDIABETIC AGENT | SANKYO COMPANY, LIMITED (JP) | 2000-08-15 | — | — | US | claimed |
| CN-1219927-A | Phenylalkylcarboxylic acid derivatives | SANKYO CO (JP) | 1999-06-16 | — | — | CN | claimed |
| EP-0916651-A1 | PHENYLALKYLCARBOXYLIC ACID DERIVATIVES | Sankyo Company, Limited (JP) | 1999-05-19 | — | — | EP | claimed |
| EP-0916651-B1 | PHENYLALKYLCARBOXYLIC ACID DERIVATIVES | SANKYO CO (JP) | 2003-10-15 | — | — | EP | disclosed |
| US-6103907-A | ALDOSE REDUCTASE INHIBITING ANTIDIABETIC AGENT | SANKYO COMPANY, LIMITED (JP) | 2000-08-15 | — | — | US | disclosed |
| CN-1219927-A | Phenylalkylcarboxylic acid derivatives | SANKYO CO (JP) | 1999-06-16 | — | — | CN | disclosed |
| EP-0916651-A1 | PHENYLALKYLCARBOXYLIC ACID DERIVATIVES | Sankyo Company, Limited (JP) | 1999-05-19 | — | — | EP | disclosed |